Wedgewood Pharmacy Recalls Compounded Veterinary Medications Over Potential Potency Inconsistencies
Wedgewood Pharmacy LLC has initiated a recall of certain compounded veterinary medications within expiry at the provider and customer level. The action was taken following internal quality findings of inconsistencies in analytical testing data generated by the company's laboratory, which could result in subpotent or superpotent products. The affected items were distributed throughout the United States between February 18, 2026, and October 6, 2026.
The recall covers multiple dosage forms, including powders, pastes, oral suspensions, injectables, ophthalmic ointments and solutions, ear preparations, topical sprays, and gels intended for companion, equine, exotic, zoo, wildlife, and aquatic animals. Low potency presents risks of treatment failure, while high potency may lead to overdose or toxicity. To date, 98 complaints have been reported, of which seven are considered serious. The medications are not intended for food-producing animals.
The recall is being conducted with the knowledge of the US FDA. Pharmacies and veterinary practices are advised to quarantine affected stock immediately, identify and alert customers who received recalled lots, and arrange for replacements or refunds. Animal owners are advised to discontinue use, retain the affected medication, and consult a veterinarian for health concerns or alternative therapies.
Key points
- Wedgewood Pharmacy is recalling multiple compounded veterinary medications due to analytical testing inconsistencies that may cause subpotency or superpotency.
- Affected formulations include injectables, oral suspensions, ophthalmic and otic preparations, pastes, powders, sprays, and gels shipped between February 18, 2026, and October 6, 2026.
- The products were prepared for companion, equine, exotic, zoo, wildlife, and aquatic species, and not for food-producing animals.
- A total of 98 complaints, including seven serious reports, have been received in connection with the affected products.
- Veterinary practices and pharmacies must quarantine affected inventory and notify clients, while animal owners are instructed to halt use and retain products.
What it means for you
Veterinary practitioners and pharmacists in Pakistan should note this US recall of compounded animal medications due to potential potency defects. Clinicians and dispensers should consult the Drug Regulatory Authority of Pakistan (DRAP) regarding the registration status, import regulations, and official guidance for any veterinary formulations. Suspected stock should be quarantined in accordance with recall directives, and continuity of animal care should be maintained using suitable alternatives.
Wedgewood Pharmacy Issues Recall of Certain Compounded Veterinary Medications Within Expiry Due to Potential Potency Issues
Summarised automatically from the official announcement. For educational purposes only — check the original source before making clinical decisions.